About this trial
The goal of this observational study is to exploratively investigate intracardiac geometry and hemodynamics in patients with ongoing HeartMate 3-therapy in the Swedish Southeast Healthcare region. The main question it aims to answer is:
\- How do different flow levels in the HeartMate 3 left ventricular assist system influence intracardiac geometry and hemodynamics?
Participating research subjects are called upon to undergo three followed photon-counting CT scans, as well as certain echocardiographic imaging, all in one session. The research subject's HeartMate device is connected to software that allows for variations in the pump's flow between these image collections. Analyzed variables includes three-dimensional geometry, CFD-computed parameters such as blood velocity, pressure, turbulence, and blood stasis. The variables are related with device settings and, alongside, selected echocardiographic measurements and patient details such as age, BMI, and diagnostic codes for both method validation and comprehensive perspective.
Eligibility criteria
Qualifiers
Connected to Linköping University Hospital ((situated in the Swedish Southeastern healthcare region)
Treatment with HeartMate 3 and implanted for > 6 months ago
Age >18 years.
Disqualifiers
Reduced kidney function (eGFR below 45 ml/min/1.73m2).
Known iodine contrast allergy
In case of untreated manifest hyperthyroidism
In case of suspected/newly diagnosed thyroid cancer where radioiodine examination/treatment may be relevant
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Region Östergötland
Lead sponsor
Linkoeping University
Collaborator